{"id":"https://openalex.org/W1968604053","doi":"https://doi.org/10.3109/10641968709161465","title":"Is Stimulation of Prejunctional Dopamine Receptors an Antihypertensive Principle?","display_name":"Is Stimulation of Prejunctional Dopamine Receptors an Antihypertensive Principle?","publication_year":1987,"publication_date":"1987-01-01","ids":{"openalex":"https://openalex.org/W1968604053","doi":"https://doi.org/10.3109/10641968709161465","mag":"1968604053","pmid":"https://pubmed.ncbi.nlm.nih.gov/3304728"},"language":"en","primary_location":{"id":"doi:10.3109/10641968709161465","doi":"https://doi.org/10.3109/10641968709161465","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10641968709161465","pdf_url":null,"source":{"id":"https://openalex.org/S203233286","display_name":"Clinical and Experimental Hypertension","issn_l":"0148-3927","issn":["0148-3927","0730-0077","1064-1963","1525-6006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Hypertension. Part A: Theory and Practice","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049898322","display_name":"Barbara J. Clark","orcid":"https://orcid.org/0000-0003-1558-1904","observed_orcids":["https://orcid.org/0000-0003-1558-1904"]},"institutions":[{"id":"https://openalex.org/I4388891806","display_name":"Sandoz Group AG (Switzerland)","ror":"https://ror.org/02rse7p59","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4388891806"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"B. J. Clark","raw_affiliation_strings":["Preclinical Research, Sandoz Ltd., CH 4002, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research, Sandoz Ltd., CH 4002, Basel, Switzerland","institution_ids":["https://openalex.org/I4388891806"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5049898322"],"corresponding_institution_ids":["https://openalex.org/I4388891806"],"apc_list":null,"apc_paid":null,"fwci":0.2264,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.225,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"5-6","first_page":"1045","last_page":"1068"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14486","display_name":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.8479999899864197},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.9399999976158142},{"id":"https://openalex.org/keywords/bromocriptine","display_name":"bromocriptine","score":0.9520000219345093},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.7300000190734863},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6700000166893005},{"id":"https://openalex.org/keywords/plasma-norepinephrine","display_name":"plasma norepinephrine","score":0.8410000205039978},{"id":"https://openalex.org/keywords/domperidone","display_name":"domperidone","score":0.9079999923706055},{"id":"https://openalex.org/keywords/cardiovascular-effects","display_name":"cardiovascular effects","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.933437705039978},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.7621023058891296},{"id":"https://openalex.org/C2775995038","wikidata":"https://www.wikidata.org/wiki/Q424238","display_name":"Domperidone","level":3,"score":0.6987927556037903},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.6405697464942932},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.6344906687736511},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6149281859397888},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.552008867263794},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5380911231040955},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5249331593513489},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5025253295898438},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4879559874534607},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46313196420669556},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.46096134185791016},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4575776755809784},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.1898266077041626},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.06409865617752075}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001971","descriptor_name":"Bromocriptine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004088","descriptor_name":"Dihydroergotoxine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/10641968709161465","doi":"https://doi.org/10.3109/10641968709161465","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10641968709161465","pdf_url":null,"source":{"id":"https://openalex.org/S203233286","display_name":"Clinical and Experimental Hypertension","issn_l":"0148-3927","issn":["0148-3927","0730-0077","1064-1963","1525-6006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Hypertension. Part A: Theory and Practice","raw_type":"journal-article"},{"id":"pmid:3304728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3304728","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental hypertension. Part A, Theory and practice","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W7830258","https://openalex.org/W54354271","https://openalex.org/W192511398","https://openalex.org/W319128806","https://openalex.org/W591319227","https://openalex.org/W1533513346","https://openalex.org/W1966370912","https://openalex.org/W1976069432","https://openalex.org/W1976304139","https://openalex.org/W1978306714","https://openalex.org/W1978765767","https://openalex.org/W1982048010","https://openalex.org/W1983432679","https://openalex.org/W1983605813","https://openalex.org/W1995049737","https://openalex.org/W2001711932","https://openalex.org/W2002450790","https://openalex.org/W2003453301","https://openalex.org/W2003711632","https://openalex.org/W2010470807","https://openalex.org/W2013165673","https://openalex.org/W2017268957","https://openalex.org/W2022950340","https://openalex.org/W2026492666","https://openalex.org/W2027837958","https://openalex.org/W2029476511","https://openalex.org/W2033132953","https://openalex.org/W2038460660","https://openalex.org/W2040500100","https://openalex.org/W2043201925","https://openalex.org/W2048522684","https://openalex.org/W2048868912","https://openalex.org/W2050671173","https://openalex.org/W2052267558","https://openalex.org/W2053239559","https://openalex.org/W2053309780","https://openalex.org/W2077684864","https://openalex.org/W2080365780","https://openalex.org/W2082579591","https://openalex.org/W2094964704","https://openalex.org/W2107648821","https://openalex.org/W2114170565","https://openalex.org/W2153787367","https://openalex.org/W2193734703","https://openalex.org/W2250122627","https://openalex.org/W2269483697","https://openalex.org/W2296320832","https://openalex.org/W2336287106","https://openalex.org/W2338638760","https://openalex.org/W2399893331","https://openalex.org/W2408891773","https://openalex.org/W2409737749","https://openalex.org/W2409811264","https://openalex.org/W2412389201","https://openalex.org/W2412542182","https://openalex.org/W2418203279","https://openalex.org/W2428084237","https://openalex.org/W2438183980","https://openalex.org/W2463778755","https://openalex.org/W2783464984","https://openalex.org/W2888871723","https://openalex.org/W4206581718","https://openalex.org/W6911096914"],"related_works":["https://openalex.org/W4235231938","https://openalex.org/W2417999786","https://openalex.org/W2035647704","https://openalex.org/W1966778267","https://openalex.org/W2077684864","https://openalex.org/W1500704870","https://openalex.org/W2045616932","https://openalex.org/W2463982268","https://openalex.org/W2296320832","https://openalex.org/W2417683789"],"abstract_inverted_index":{"Bromocriptine":[0],"and":[1,8,70,105,109],"co-dergocrine":[2,106],"(Hydergine":[3],"R)":[4],"reduce":[5],"blood":[6],"pressure":[7],"heart":[9],"rate":[10],"in":[11,28,74,79,107,119],"experimental":[12],"animals":[13,108],"largely":[14],"by":[15,54,85],"stimulating":[16],"DA2":[17,55,114],"receptors.":[18],"A":[19,93],"stimulant":[20,116],"effect":[21],"on":[22],"DA1":[23],"receptors":[24],"can":[25,82],"be":[26,83],"demonstrated":[27],"isolated":[29],"tissues,":[30],"but":[31],"this":[32],"action":[33],"does":[34],"not":[35],"appear":[36],"to":[37,42,46,63],"make":[38],"an":[39],"important":[40],"contribution":[41],"the":[43,47,65,71,96,100,120],"depressor":[44],"response":[45],"two":[48],"compounds,":[49],"since":[50],"effects":[51,102],"are":[52,61],"abolished":[53],"receptor":[56,115],"blockade.":[57],"Although":[58],"both":[59],"compounds":[60],"known":[62],"penetrate":[64],"brain,":[66],"their":[67],"antihypertensive":[68],"effects,":[69],"concomitant":[72],"reductions":[73],"plasma":[75],"noradrenaline":[76],"levels":[77],"produced":[78],"hypertensive":[80],"patients":[81],"prevented":[84],"domperidone,":[86],"confirming":[87],"a":[88,113],"peripheral":[89],"site":[90],"of":[91,95,103,122],"action.":[92],"review":[94],"data":[97],"available":[98],"concerning":[99],"cardiovascular":[101],"bromocriptine":[104],"man":[110],"suggests":[111],"that":[112],"is":[117],"effective":[118],"treatment":[121],"hypertension.":[123]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}